Fri, Mar 6, 2015, 7:15 AM EST - U.S. Markets open in 2 hrs 15 mins

Recent

% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

whippersnapper65 189 posts  |  Last Activity: 9 hours ago Member since: Jun 20, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • whippersnapper65 whippersnapper65 9 hours ago Flag

    I agree with you that volume will probably increase to the level at which it will average at least 3.5-4 million shares per day from now on.

    Sentiment: Strong Buy

  • whippersnapper65 whippersnapper65 9 hours ago Flag

    I think a technician could make a case that a consolidation phase after the runup over the past two weeks could take the share price down to 25 or 24 where it would find support. You could view a long-term chart and see that a wide u-shaped cup has been formed over the past year, with the rim at $31. If a bullish cup and handle formation were to be formed, there would now be a brief consolidation pullback that would form a handle down to $24-$25 before returning to $31 to complete the handle, and after that it would be sky's the limit since an extremely bullish and well-consolidated pattern would have formed a base of support at $31 to serve as a launch pad for a new rally. Combine the technical strength with the fundamental strength and news going into ASCO, as well as the short squeeze potential, and you have the preconditions for a strong rally.

    Sentiment: Strong Buy

  • whippersnapper65 whippersnapper65 14 hours ago Flag

    ReACT complete data set will be available by May. Celldex management will share those data with the FDA even before they are made public at ASCO. Swift action by the FDA on the basis of the complete data set could result in early approval of Rintega before the end of this year. It should be done that way. To delay approval is to deny terminally ill patients a desperately needed and effective therapy. The speed with which Opdivo was granted approval bolsters the case that Rintega will be granted early approval this year.

    Sentiment: Strong Buy

  • whippersnapper65 whippersnapper65 15 hours ago Flag

    CLDX will be similar: it could have been had for a little over $2 per share in 2011. Will fetch a very hefty price per share by 2017, whether it remains independent or not.

    Sentiment: Strong Buy

  • Reply to

    OK who stops were taken out?

    by grey3840 18 hours ago
    whippersnapper65 whippersnapper65 17 hours ago Flag

    I don't think they're done harvesting trailing stops yet. We've seen very ugly, sudden drops in the past, and that was before the picture of Celldex's future success was as clear as it is now. Institutions will be all the more eager to pry shares loose from heretofore strong hands or new hands at a bargain price in order to benefit from the inevitable tripling and quadrupling of the share price, and even higher prices. Do not set trailing stops at all!

    Sentiment: Strong Buy

  • whippersnapper65 whippersnapper65 19 hours ago Flag

    I interpret that moniker as meaning he's only used 30 rubbers in his lifetime.

  • Reply to

    Dorris

    by gerald_pontificus 22 hours ago
    whippersnapper65 whippersnapper65 22 hours ago Flag

    They're still here, but their presence is limited to giving longs' posts red thumbs down because they're too embarrassed and cowardly to post their short blather anymore since it's obvious even to them that they were wrong.

    Sentiment: Strong Buy

  • Reply to

    Massive short position

    by cash2go Mar 4, 2015 5:26 PM
    whippersnapper65 whippersnapper65 Mar 4, 2015 5:44 PM Flag

    If you've been around CLDX as long as some of us have, you know to be prepared for shenanigans with the share price as institutions will use volatility to trigger stops so that they can accumulate more shares. Even stops that you'd think are safe -- set to trail at $3-$4 -- are not safe from being triggered in a false move down. We have seen $2-$3 moves down followed by sharp turns back up in price, and some people have had their shares "stolen" from them at a bargain price. To anyone who is new to CLDX: if you want to hold on to your shares, do not set a stop loss order. Institutions want as many shares as they can amass, and they will bring CLDX down sharply in the blink of an eye in order to get your shares from you. You won't have time to respond manually.

    Sentiment: Strong Buy

  • Celldex management continues to push forward in ways that telegraph that commercialization is imminent and virtually guaranteed:

    Associate/Specialist Regulatory Affairs Publisher & Operations (Needham, MA)

    Overview:

    Celldex is looking for an individual with experience in publishing documents for regulatory submissions. The ideal candidate will assist in the day-to-day regulatory operations activities such as; archiving and organizing the publishing logistics for IND safety report submissions, IND monthly submissions, and IND annual reports.

    Individual responsibilities include:
    •Publishes regulatory documents and submits to applicable agencies.
    •Assists in planning and organizing submissions to regulatory agencies.
    •Organizes and tracks the progress of planned regulatory submissions within defined timelines, in collaboration with the regulatory product leaders and cross functional teams.
    •Assists in the training of formatting standards and publishing process to other members of the product development team.

    Sentiment: Strong Buy

  • Reply to

    NET has then STANDING and APPLAUDING...

    by frankfrazzano Mar 3, 2015 11:39 AM
    whippersnapper65 whippersnapper65 Mar 3, 2015 11:46 AM Flag

    I agree with the Prime Minister and the content of his speech, but his speech is mediocre.

  • whippersnapper65 by whippersnapper65 Mar 3, 2015 11:44 AM Flag

    longs will prevail
    the science of Celldex's immunotherapy treatments cannot be disregarded much longer
    when the current round of tug-of-war ends, the pps will surge toward $30
    shorts will be squeezed after that, propelling the pps into the mid $30s

    Sentiment: Strong Buy

  • Reply to

    smart shorts covering

    by raya_q8 Mar 2, 2015 3:54 PM
    whippersnapper65 whippersnapper65 Mar 2, 2015 4:04 PM Flag

    Smart shorts covered at $17 and below. Now here we are $10 above that level just a short time later. The only shorts left are dumb ones.

    Sentiment: Strong Buy

  • Reply to

    Poison pill???

    by njcheesehead05 Mar 1, 2015 7:49 PM
    whippersnapper65 whippersnapper65 Mar 1, 2015 9:45 PM Flag

    The Shareholder Rights Plan does not appear in the 2014 10K whereas it did appear in the 2013 10K along with the explanation that it expired in November 2014. The Shareholder Rights Plan is no longer active. Thus there would seem to be no "poison pill" obstacle to prevent or discourage an institution from acquiring 15% or more of Celldex's outstanding shares.

    FMR might have been deliberately careful about acquiring precisely 14.999% of Celldex's shares in the 4th quarter until it was confirmed in the 2014 10K that the Shareholder Rights Plan had not been renewed or extended. Now that institutions know the plan has expired, they are free to acquire as many shares as they want without impediment.

    Of course, with the recent secondary offering, unless FMR has purchased more shares its ownership percentage has decreased from the 14.999% it declared as of December 31.

    I would like to see institutions bid up the share price as they clamor for shares in an effort to boost their ownership percentages.

    Sentiment: Strong Buy

  • Reply to

    Gov. Walker

    by microcaplawyer Mar 1, 2015 7:57 PM
    whippersnapper65 whippersnapper65 Mar 1, 2015 9:26 PM Flag

    Please explain how it is fascist to give government employees the right and freedom to decide for themselves whether they want to pay union dues rather than (as the big, leftist, government union thugs would have it) forcing government employees to contribute union dues they do not want to contribute. Since Walker's electoral, legislative and court victories against the big, leftist, government unions, unions in Wisconsin have seen their dues collection plummet dramatically as employees have opted out and their political influence wane considerably because they have much less money to spend advocating for leftist causes. Unions are not about freedom; they are about leftist totalitarianism. Government unions are further an instance of using taxpayer money to advocate against taxpayer interest. You are applying the term "fascism" (which you obviously do not understand) toward the wrong party.

  • Reply to

    Gov. Walker

    by microcaplawyer Mar 1, 2015 7:57 PM
    whippersnapper65 whippersnapper65 Mar 1, 2015 8:34 PM Flag

    Governor Walker won against the unions in Wisconsin several times, and he has turned that state's economy and government budget around back in a positive direction because he has successfully stood up against and defeated the big, leftist, government union thugs.

    Yes, there are union thugs just as there are ISIS thugs. Governor Walker knows all about the terrorist, character assassination tactics of big, leftist, government union thugs. Big, leftist, government union thugs don't want freedom just as ISIS terrorists don't want freedom: both want their way, and they will attempt to destroy anyone who gets in their way or threatens their agendas.

  • Reply to

    Dilution at this time was smart

    by zanghia Mar 1, 2015 2:03 PM
    whippersnapper65 whippersnapper65 Mar 1, 2015 2:38 PM Flag

    You misunderstand: the recent raising of money via a secondary offering wasn't to fund a trial; it was to raise sufficient capital to bring Rintega to market after early approval without jeopardizing any of the other programs in development that Celldex is already funding. The company had adequate cash reserves to fund operation through 2016, but the CEO added something new during Tuesday morning's conference call: if the FDA were to grant early approval to Rintega, the company would need more money to cover the additional expenses required to bring it to market. Lo and behold, that same afternoon Celldex announced it was raising an additional $175-$200 million dollars. That was not a coincidence; that was a perfectly planned and executed series of events to communicate to investors that Rintega will be granted early approval.

    Sentiment: Strong Buy

  • Reply to

    Institutional Ownership 85.41%

    by thegreyfog Mar 1, 2015 7:48 AM
    whippersnapper65 whippersnapper65 Mar 1, 2015 8:41 AM Flag

    If you notice on the NASDAQ site, the number of outstanding shares has increased to 97 million abruptly.

    It is clear that the abrupt change in the IO and in the total shares is a direct result of the secondary offering. Those shares are now in circulation, increasing the total shares outstanding. There is no official record of institutions having purchased those new shares, and until such a record is filed with the SEC NASDAQ cannot assume that the shares are in institutional hands; thus the new shares are not counted among institutional ownership, which accounts for the drop from 92% to 85%.

    I believe those new shares have been purchased by institutions, not by retail, and when the SEC filings show updated institutional ownership the IO percentage will be close to 95%.

    Not to worry. Institutions are increasing their holdings of CLDX. The data you noticed is a result of making a new calculation on the basis of incomplete information.

    Sentiment: Strong Buy

  • Reply to

    Reason to Hold Down the Stock Announced

    by bcrx50in2007 Feb 27, 2015 12:36 PM
    whippersnapper65 whippersnapper65 Feb 27, 2015 12:58 PM Flag

    It's already a ten-bagger for some of us. Another ten-fold increase would turn it into a 100-bagger. It will happen. CLDX is a paradigm-changing company, and there is still much growth in share price to come.

    Sentiment: Strong Buy

  • Reply to

    AF gives bullish dialogue on Celldex

    by flogonuzim Feb 27, 2015 6:40 AM
    whippersnapper65 whippersnapper65 Feb 27, 2015 7:08 AM Flag

    I don't understand why it would take until mid 2016 for Rintega to be approved early. Heck, ACT IV might have been stopped early for statistically significant efficacy by then. If the complete data set for ReACT is consistent with November's statistically significant results in OS and other measurements, then the FDA could and should decide very easily this summer to grant early approval at least in relapsed GBM patients. Presumably, the FDA has already reviewed all Rintega data available to date and found it to be supportive of consideration for a new therapy that serves an unmet and desperate need, otherwise breakthrough designation would not have been granted. To look at the complete ReACT data set and reach a positive decision regarding its early approval ought not to take a whole year from when the data will be available in May of this year.

    Sentiment: Strong Buy

  • Reply to

    celldex therapeutics

    by gerald_pontificus Feb 26, 2015 1:42 PM
    whippersnapper65 whippersnapper65 Feb 26, 2015 1:46 PM Flag

    I am smiling. It's been a longer road than I had hoped for when I first purchased shares, but we will get there and it will be beautiful.

    Sentiment: Strong Buy

CLDX
29.78+0.48(+1.64%)Mar 5 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Geron Corporation
NASDAQThu, Mar 5, 2015 4:00 PM EST
Vivint Solar, Inc.
NYSEThu, Mar 5, 2015 4:00 PM EST
AbbVie Inc.
NYSEThu, Mar 5, 2015 4:02 PM EST